Delisting of Securities of Liberty Resources Acquisition Corp.; Achari Ventures Holdings Corp. I; PetVivo Holdings, Inc.; Galera Therapeutics, Inc.; Clean Energy Special Situations Corp.; Capitalworks Emerging Markets Acquisition Corp.; AERWINS...
ガレラ・セラピューティクス | 10-Q:Q2 2024 四半期報告書
Galera Therapeutics: Reducing Workforce to Three Employees Effective Aug. 31 >GRTX
Galera Therapeutics 2Q Loss $4.06M >GRTX
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Why Galera Therapeutics (GRTX) Stock Is Nosediving
Galera Therapeutics Shares Are Trading Lower After the Company Announced It Will Be Delisted by Nasdaq.
Wall Street Set to Open Slightly Higher Monday as Investors Await Key Manufacturing Data for May
Top Premarket Decliners
ガレラ セラピューティクス | 10-Q:Q1 2024 四半期報告書
Galera Therapeutics Q1 2024 GAAP EPS $(0.08) Beats $(0.35) Estimate
Galera Therapeutics Had Cash and Cash Equivalents of $13.5M at March 31 >GRTX
Galera Therapeutics: Evaluation of Potential Strategic Alternatives Progresses With Goal to Maximize Stockholder Value >GRTX
Galera Therapeutics 1Q Loss $4.38M >GRTX
Galera Adopts Limited Duration Stockholder Rights Agreement
【SEC訂正報告書】ガレラ・セラピューティクス(GRTX.US)、主要株主が59.04万ドルで普通株278.04万株を取得
米国証券取引委員会(SEC)が5月1日に開示した文書によると、$ガレラ・セラピューティクス(GRTX.US)$の主要株主Schneid Yairは、2014年4月17日および2024年4月17日、18日、19日に1株平均0.2124ドルで普通株278.04万株を取得、合計額は約59.04万ドル。出所:SEC 株式保有報告書とは何かSECは上場会社の内部者 (インサイダー) に対し、株式取引や保有状
Galera Therapeutics Received A Notice Of Allowance For Its U.S Patent Application 17/378,852 Titled "Pentaaza Macrocyclic Ring Complexes Possessing Oral Bioavailability (To Reduce Oral Mucositis In Head-And-Neck Cancer Patients From Chemoradiation)"
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
Galera Therapeutics, (GRTX) Sees Unprecedented After-Hours Surge
データなし
データなし